VX18-445-104


Study NameStudy TitleStudy TypeSponsorSponsor Type
VX18-445-104A phase 3, randomized, double blind, controlled study evaluating the efficacy and safety of VX-445 combination therapy in subjects with cystic fibrosis who are heterozygous for the FR508del mutation and a gating or residual function mutation (F/G and F/RF genotypes)Clinical TrialVertexIndustry Sponsored